Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood test
MedTech
Quest Diagnostics taps MD Anderson for cancer risk blood test
Dubbed the multi-cancer stratification test, or MCaST, Quest said it may help identify people who could benefit from more frequent screenings.
Conor Hale
Jun 10, 2025 2:11pm
FDA clears its first blood test for diagnosing Alzheimer's
May 16, 2025 4:30pm
Roche launches liver fibrosis blood test for MASLD
May 7, 2025 10:30am
Abbott’s rapid blood-based concussion test is off to the races
May 6, 2025 10:00am
Exact Sciences plans 'transformative year' with new cancer tests
May 1, 2025 4:05pm
Caris Life Sciences collects $168M to fund tumor test rollouts
Apr 9, 2025 11:51am
